Sword Health announced the launch of what it calls the world’s first platform to predict, prevent and treat pain. With its products now used by members of more than 2,500 companies across three continents, Sword is turning everything it has learned about making optimal clinical-grade treatments more accessible into a single platform that can help people avoid and treat the pain that afflicts 60% of adults each year according to the CDC.
Since its market entry in 2020, Sword has been focused on companies’ number one healthcare cost – back, joint, and muscle pain.
Sword said it holds the majority of industry patents, wins 70% of competitive evaluations, and has raised more than $300 million from top venture firms like Founders Fund, General Catalyst, and Khosla Ventures. Read more.
